Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHASERR is a long noncoding RNA (lncRNA) located adjacent to the CHD2 gene on chromosome 15. It functions as a cis-acting transcriptional repressor of CHD2, regulating its expression and maintaining proper chromatin remodeling activity. Deletions or haploinsufficiency of CHASERR are associated with a distinct syndromic neurodevelopmental disorder characterized by severe developmental delay, early-onset encephalopathy, facial dysmorphisms, and cerebral hypomyelination/cortical atrophy.
Cis-acting transcriptional repressor of CHD2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CHD2 adjacent suppressive regulatory RNA.